ACHPN Study Questions with complete
solutions 2024
In jproviding jeducation jabout jthe jprevention jof jHIV/AIDS, jwhich jof jthe jfollowing
jstatements jwould jthe jpalliative jAPRN jstate jis jthe jmost jeffective jaction?
A. jEarly jinitiation jof jprophylactic jantiviral jdrug jtherapy
B. jSuggestion jof jtotal jsexual jabstinence
C. jOral jsexual jencounters jonly
D. jUse jof jcondoms jwith jor jwithout ja jspermicidal jagent. j- jANS✓✓-D. jUse jof
jcondoms jwith jor jwithout ja jspermicidal jagent.
A jpatient jmeets jwith jtheir jprimary jcare jAPRN jand jreports jfever jand jflu-like
jsymptoms. jThe jpatient jreports jthat jthey jhave jhad jsexual jencounters jwith
jmales jand jis jworried jthat jthey jhe jmay jhave jHIV. jGiven jtheir jsymptoms, jwhat
jis jthe jmost jappropriate jlaboratory jtest jthat jwould jbe jsensitive jto jHIV jat jthis
jstage?
A. jAn jantibody jlab jtest.
B. jAn jantibody-antigen jlab jtest.
C. jAn jELISA jlab jtest.
D. jA jnucleic jacid jlab jtest. j- jANS✓✓-C. jAn jELISA j(enzyme-linked
jimmunosorbent jassay) jlab jtest
Which jorganism jis jresponsible jfor jan jincrease jin jcervical jcancer jin jwomen jand
jincreased janal jcancer jin jmen?
A. jCandida jalbicans jfungal jinfection
B. jCryptococcus jneoformans jinfection
C. jEpstein-Barr jviral jinfection
D. jHuman jpapillomavirus jinfection j- jANS✓✓-D. jHuman jpapillomavirus jinfection
The jAPRN jis jpreparing jto jvisit ja jfemale jpatient jwith ja jsix jyear jhistory jof
jsystemic jlupus jerythematosus. jThe jpatient jcomplains jof jfatigue, jintermittent
jfever, jand jmyalgias. jWhich jstatement jabout jlupus jdisease jprogression jwould
jbest jguide jthe jAPRN's jphysical jassessment jand jdiagnostic jworkup?
A. jProduction jof jexcess jwhite jblood jcells.
B. jProduction jof jexcess jred jblood jcells.
C. jProduction jof jantinuclear jantibodies.
D. jProduction jof jhigh juric jnitrogen. j- jANS✓✓-C. jProduction jof jantinuclear
jantibodies.
, Which jof jthe jfollowing jstatements jbest jdescribes jthe jfatigue jexperienced jby
jpatients jwith jsystemic jlupus jerythematosus?
A. jFatigue jexperienced jby jlupus jpatients jis jintermittent jand jmild jin
jpresentation.
B. jFatigue jexperienced jby jlupus jpatients jis jbest jcorrelated jwith jepisode jof
jinfection.
C. jThe jfatigue jexperienced jby jpatients jwith jlupus jis jrelated jto jthe juse jof jlong-
term jcorticosteroids.
D. jFatigue jis jthe jmost jcommon jsymptom jin jlupus jand jcan jbe jdisabling. j-
jANS✓✓-D. jFatigue jis jthe jmost jcommon jsymptom jin jlupus jand jcan jbe
jdisabling.
Physical jexamination jfindings jof jrheumatoid jarthritis jinclude jwhich jof jthe
jfollowing?
A. jUnilateral jjoint jinvolvement.
B. jStiffness jlasting jmost jof jthe jday.
C. jJoint jdeformities jin jthe jdistal jphalanges.
D. jLower jback jpain jand jstiffness. j- jANS✓✓-C. jJoint jdeformities jin jthe jdistal
jphalanges.
*affects jPIP j(Bouchard's jnodes) jand jswan jneck jdeformities
Treatment jfor jrheumatoid jarthritis jis jgeared jtoward jwhich jgoal
A. jTo jrelieve jsymptoms jand jdecrease jprogression jof jdisease
B. jTo jalter jthe jetiology jof jthe jdisease
C. jTo jcure jthe jdisease
D. jTo jreduce jthe jnumber jof jmedications j- jANS✓✓-A. jTo jrelieve jsymptoms jand
jdecrease jprogression jof jdisease
A jpatient jwith jRA jmay jhave jdecreased jquality jof jlife jdue jto jall jof jthe jfollowing
jEXCEPT?
A. jDepression
B. jJoint jhypermobility
C. jGeneralized jpain
D. jFatigue j- jANS✓✓-B. jJoint jhypermobility
A jpatient jwith jRA jis jstarted jon jDMARD. jMonitoring jof jthe jdisease jincludes
jwhich jof jthe jfollowing?
A. jYearly jeye jexaminations
B. jReporting jany jevidence jof jinfection
C. jMonitoring jWBC jcounts jfor jlevel jof j5,000
D. jNo jspecial jmonitoring jneeded j- jANS✓✓-B. jReporting jany jevidence jof
jinfection
The jpatient jwith jsevere jcombined jimmunodeficiency jdisease jmay jpresent jwith
jwhich jof jthe jfollowing jsigns jand jsymptoms?
solutions 2024
In jproviding jeducation jabout jthe jprevention jof jHIV/AIDS, jwhich jof jthe jfollowing
jstatements jwould jthe jpalliative jAPRN jstate jis jthe jmost jeffective jaction?
A. jEarly jinitiation jof jprophylactic jantiviral jdrug jtherapy
B. jSuggestion jof jtotal jsexual jabstinence
C. jOral jsexual jencounters jonly
D. jUse jof jcondoms jwith jor jwithout ja jspermicidal jagent. j- jANS✓✓-D. jUse jof
jcondoms jwith jor jwithout ja jspermicidal jagent.
A jpatient jmeets jwith jtheir jprimary jcare jAPRN jand jreports jfever jand jflu-like
jsymptoms. jThe jpatient jreports jthat jthey jhave jhad jsexual jencounters jwith
jmales jand jis jworried jthat jthey jhe jmay jhave jHIV. jGiven jtheir jsymptoms, jwhat
jis jthe jmost jappropriate jlaboratory jtest jthat jwould jbe jsensitive jto jHIV jat jthis
jstage?
A. jAn jantibody jlab jtest.
B. jAn jantibody-antigen jlab jtest.
C. jAn jELISA jlab jtest.
D. jA jnucleic jacid jlab jtest. j- jANS✓✓-C. jAn jELISA j(enzyme-linked
jimmunosorbent jassay) jlab jtest
Which jorganism jis jresponsible jfor jan jincrease jin jcervical jcancer jin jwomen jand
jincreased janal jcancer jin jmen?
A. jCandida jalbicans jfungal jinfection
B. jCryptococcus jneoformans jinfection
C. jEpstein-Barr jviral jinfection
D. jHuman jpapillomavirus jinfection j- jANS✓✓-D. jHuman jpapillomavirus jinfection
The jAPRN jis jpreparing jto jvisit ja jfemale jpatient jwith ja jsix jyear jhistory jof
jsystemic jlupus jerythematosus. jThe jpatient jcomplains jof jfatigue, jintermittent
jfever, jand jmyalgias. jWhich jstatement jabout jlupus jdisease jprogression jwould
jbest jguide jthe jAPRN's jphysical jassessment jand jdiagnostic jworkup?
A. jProduction jof jexcess jwhite jblood jcells.
B. jProduction jof jexcess jred jblood jcells.
C. jProduction jof jantinuclear jantibodies.
D. jProduction jof jhigh juric jnitrogen. j- jANS✓✓-C. jProduction jof jantinuclear
jantibodies.
, Which jof jthe jfollowing jstatements jbest jdescribes jthe jfatigue jexperienced jby
jpatients jwith jsystemic jlupus jerythematosus?
A. jFatigue jexperienced jby jlupus jpatients jis jintermittent jand jmild jin
jpresentation.
B. jFatigue jexperienced jby jlupus jpatients jis jbest jcorrelated jwith jepisode jof
jinfection.
C. jThe jfatigue jexperienced jby jpatients jwith jlupus jis jrelated jto jthe juse jof jlong-
term jcorticosteroids.
D. jFatigue jis jthe jmost jcommon jsymptom jin jlupus jand jcan jbe jdisabling. j-
jANS✓✓-D. jFatigue jis jthe jmost jcommon jsymptom jin jlupus jand jcan jbe
jdisabling.
Physical jexamination jfindings jof jrheumatoid jarthritis jinclude jwhich jof jthe
jfollowing?
A. jUnilateral jjoint jinvolvement.
B. jStiffness jlasting jmost jof jthe jday.
C. jJoint jdeformities jin jthe jdistal jphalanges.
D. jLower jback jpain jand jstiffness. j- jANS✓✓-C. jJoint jdeformities jin jthe jdistal
jphalanges.
*affects jPIP j(Bouchard's jnodes) jand jswan jneck jdeformities
Treatment jfor jrheumatoid jarthritis jis jgeared jtoward jwhich jgoal
A. jTo jrelieve jsymptoms jand jdecrease jprogression jof jdisease
B. jTo jalter jthe jetiology jof jthe jdisease
C. jTo jcure jthe jdisease
D. jTo jreduce jthe jnumber jof jmedications j- jANS✓✓-A. jTo jrelieve jsymptoms jand
jdecrease jprogression jof jdisease
A jpatient jwith jRA jmay jhave jdecreased jquality jof jlife jdue jto jall jof jthe jfollowing
jEXCEPT?
A. jDepression
B. jJoint jhypermobility
C. jGeneralized jpain
D. jFatigue j- jANS✓✓-B. jJoint jhypermobility
A jpatient jwith jRA jis jstarted jon jDMARD. jMonitoring jof jthe jdisease jincludes
jwhich jof jthe jfollowing?
A. jYearly jeye jexaminations
B. jReporting jany jevidence jof jinfection
C. jMonitoring jWBC jcounts jfor jlevel jof j5,000
D. jNo jspecial jmonitoring jneeded j- jANS✓✓-B. jReporting jany jevidence jof
jinfection
The jpatient jwith jsevere jcombined jimmunodeficiency jdisease jmay jpresent jwith
jwhich jof jthe jfollowing jsigns jand jsymptoms?
